Mycophenolic acid Completed Phase 2 Trials for Myelodysplastic Syndromes / Myelodysplastic/Myeloproliferative Neoplasms / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00045305Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes